Adicet Announces Completion of Merger with resTORbio
– Adicet Emerges as a Leading Allogeneic Gamma Delta T Cell Therapy Company Focused on Oncology –-Trading to Commence on […]
Virgil’s™ Brings Back Limited-Edition Bavarian Nutmeg Swing-lid Root Beer
NORWALK, Conn., Sept. 15, 2020 (GLOBE NEWSWIRE) — Virgil’s™, America’s best-selling line of natural, handcrafted and zero sugar sodas from […]
Rizobacter and Marrone Bio Innovations form a Strategic Alliance to Deploy Novel Plant Health and Crop Nutrition Technology in South America
PERGAMINO, Argentina and DAVIS, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) — Rizobacter, a subsidiary of Bioceres Crop Solutions Corp. (NYSE: […]
ORBCOMM Appoints Rick Ochsendorf as Senior Vice President of Customer Operations for Its North America Transportation Business
ROCHELLE PARK, N.J., Sept. 15, 2020 (GLOBE NEWSWIRE) — ORBCOMM Inc. (Nasdaq: ORBC), a global provider of Internet of Things […]
Aerpio Announces Enrollment Completed in the 28-Day Phase 2 Razuprotafib Glaucoma Trial
CINCINNATI, Sept. 15, 2020 (GLOBE NEWSWIRE) — Aerpio Pharmaceuticals, Inc.(“Aerpio”) (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that […]
Ziopharm Oncology Appoints Four Additional Members to Scientific Advisory Board
BOSTON, Sept. 15, 2020 (GLOBE NEWSWIRE) — Ziopharm Oncology, Inc. (“Ziopharm” or “the Company”) (Nasdaq: ZIOP), today announced the appointment […]
Energy Focus Awarded Exclusive Contract Valued at Up To $4.8 Million from U.S. Navy
Also Awarded a GSA Schedule Contract to Allow Direct Sales to Federal Government Agencies and BuildingsSOLON, Ohio, Sept. 15, 2020 […]
Fluidigm Announces Agenda for 9th Annual Mass Cytometry Summit
Virtual Event Showcases CyTOF Technology and Its Use in High-Parameter Suspension Mass Cytometry and Imaging Mass CytometryLeading Academic and Pharma […]
Equillium Announces Successful Completion of FDA Pre-IND Meeting Enabling Advancement of Itolizumab into a Potential Registration Study as a Treatment for Hospitalized COVID-19 Patients
Equillium anticipates filing a U.S. IND for Itolizumab for COVID-19 and initiating a global Phase 3 clinical study in Q4 […]
EDAP Hosting Key Opinion Leader Call on Focal One® and ExactVu™
Call to be Held Tuesday, September 22nd @ 8am Eastern TimeLYON, France, September 15, 2020 — EDAP TMS SA (Nasdaq: […]
